Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

BACKGROUND: The efficacy of BCG may be enhanced by heterologous vaccination strategies that boost the BCG-primed immune response. One leading booster vaccine, MVA85A, has shown promising safety and immunogenicity in UK human trials. We investigated the safety and immunogenicity of MVA85A in mycobact...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hawkridge, Tony, Scriba, Thomas J., Gelderbloem, Sebastian, Smit, Erica, Tameris, Michele, Moyo, Sizulu, Lang, Trudie, Veldsman, Ashley, Hatherill, Mark, van der Merwe, Linda, Fletcher, Helen A, Mahomed, Hassan, Hill, Adrian V.S., Hanekom, Willem A., Hussey, Gregory D., McShane, Helen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822902/
https://ncbi.nlm.nih.gov/pubmed/18582195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/590185
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller